{
  "ticker": "LH",
  "year": 2022,
  "quarter": 4,
  "last_updated": "2025-04-15T14:01:53.509490",
  "count": 12,
  "transactions": [
    {
      "id": 28662,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 53855,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 28660,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 28661,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 53837,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 53838,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 28656,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 28659,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 28667,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 53827,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 53832,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 53910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    }
  ]
}